HAM
RGNX icon

HHR Asset Management’s Regenxbio RGNX Stock Holding History

HHR Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,130
Closed -$1.05M – 45
2020
Q4 		$1.05M Sell
23,130
-8,000
-26% -$280K 0.09% 37
2020
Q3 		$857K Sell
31,130
-1,770
-5% -$57.7K 0.09% 34
2020
Q2 		$1.21M Sell
32,900
-5,450
-14% -$203K 0.12% 35
2020
Q1 		$1.24M Hold
38,350
– – 0.14% 38
2019
Q4 		$1.57M Sell
38,350
-3,830
-9% -$151K 0.15% 33
2019
Q3 		$1.5M Hold
42,180
– – 0.15% 33
2019
Q2 		$2.17M Buy
+42,180
New +$2.11M 0.16% 42

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HHR Asset Management's RGNX Position: Q1 2021 in Review

HHR Asset Management sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 23,130 shares — an estimated $1.05M sold.

HHR Asset Management first reported a position in RGNX in Q2 2019 and held it in 7 quarters. The position peaked at $2.17M in Q2 2019. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

  • HHR Asset Management reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
  • HHR Asset Management sold 23,130 Regenxbio shares in Q1 2021, an estimated $1.05M.
  • HHR Asset Management first reported a position in Regenxbio in Q2 2019 and held it in 7 quarters.
  • HHR Asset Management's Regenxbio position peaked at $2.17M in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on HHR Asset Management's 13F filing for Q1 2021, filed 17 May 2021.